Tobradex St Suspension/ Drops
Product Images NDC 82667-011

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Tobradex St (NDC 82667-011). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Harrow Eye, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Tobradexst_carton (Tobradex St Trade Carton)

Tobradexst_carton (Tobradex St   Trade Carton)
Packaging label for Tobradex ST ophthalmic suspension drops by Harrow Eye, LLC. The sterile suspension contains tobramycin 0.3% and dexamethasone 0.05% in a 5 mL bottle. The label includes dosage, storage instructions, and a barcode, with Harrow Eye's logo and contact information. NDC 82667-011-05 is displayed.*
FDA Label Image

Chemical Structure (Tobradex 01)

Chemical Structure (Tobradex 01)
Chemical structure diagram of the active ingredient tobramycin in Tobradex ST ophthalmic suspension/drops.*
FDA Label Image

Chemical Structure (Tobradex 02)

Chemical Structure (Tobradex 02)
Chemical structure of dexamethasone, one of the active ingredients in Tobradex ST ophthalmic suspension/drops by Harrow Eye, LLC.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.